Niagen Bioscience (NAGE) Gross Margin: 2010-2025
Historic Gross Margin for Niagen Bioscience (NAGE) over the last 14 years, with Sep 2025 value amounting to 64.52%.
- Niagen Bioscience's Gross Margin rose 103.00% to 64.52% in Q3 2025 from the same period last year, while for Sep 2025 it was 63.89%, marking a year-over-year increase of 245.00%. This contributed to the annual value of 61.84% for FY2024, which is 107.00% up from last year.
- According to the latest figures from Q3 2025, Niagen Bioscience's Gross Margin is 64.52%, which was down 0.74% from 65.00% recorded in Q2 2025.
- Niagen Bioscience's 5-year Gross Margin high stood at 65.00% for Q2 2025, and its period low was 57.23% during Q4 2022.
- In the last 3 years, Niagen Bioscience's Gross Margin had a median value of 61.40% in 2023 and averaged 62.09%.
- In the last 5 years, Niagen Bioscience's Gross Margin spiked by 495bps in 2021 and then plummeted by 397bps in 2022.
- Over the past 5 years, Niagen Bioscience's Gross Margin (Quarterly) stood at 61.20% in 2021, then tumbled by 397bps to 57.23% in 2022, then soared by 381bps to 61.04% in 2023, then skyrocketed by 144bps to 62.48% in 2024, then spiked by 103bps to 64.52% in 2025.
- Its Gross Margin was 64.52% in Q3 2025, compared to 65.00% in Q2 2025 and 63.42% in Q1 2025.